[Federal Register Volume 68, Number 118 (Thursday, June 19, 2003)]
[Notices]
[Page 36858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15575]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Emergency Clearance: Public Information Collection Requirements 
Submitted to the Office of Management and Budget (OMB)

AGENCY: Executive Office of the President, Office of National Drug 
Control Policy
    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Executive Office of the President, 
Office of National Drug Control Policy, is publishing the following 
summary of proposed information collections for public comment. 
Interested persons are invited to send comments regarding this burden 
estimate or any other aspect of this collection of information, 
including any of the following subjects: (1) The necessity and utility 
of the proposed information collection for the proper performance of 
the agency's functions; (2) the accuracy of the estimated burden; (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; and (4) the use of automated collection techniques or 
other forms of information technology to minimize the information 
collection burden.
    We are, however, requesting an emergency review of the information 
collection referenced below. In compliance with the requirement of 
section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we have 
submitted to the Office of Management and Budget (OMB) the following 
requirements for emergency review. We are requesting an emergency 
review because the collection of this information is needed before the 
expiration of the normal time limits under OMB's regulations at 5 CFR 
part 1320. We cannot reasonably comply with the normal clearance 
procedures because of the urgent need for this critical information in 
the formulation of ONDCP's major national policy initiative regarding 
student drug testing beginning fiscal year 2004. ONDCP's formulation of 
its national policy initiative regarding student drug testing will rely 
heavily on the data collected through this effort.
    Executive Office of the President, Office of National Drug Control 
Policy is requesting OMB review and approval of this information 
collection thirty two days from the date of publication, with an 180-
day approval period. Written comments and recommendations will be 
accepted from the public if received by the individuals designated 
below within 30 days from the date of publication.
    Type of Information Collection Request: New collection;
    Title of Information Collection: Survey--Identifying Public/Private 
Schools Currently Operating School Drug Testing Programs in 25 Cities 
Across the U.S;
    Use: To identify schools or school districts that currently conduct 
student drug testing programs, and to assess the common characteristics 
of existing programs;
    Frequency: Onetime reporting;
    Affected Public: State, Local, or Tribal Government, not-for-profit 
institutions;
    Number of Respondents: 4368;
    Total Annual Responses: 4368;
    Total Annual Hours: 1092.
    We have submitted a copy of this notice to OMB for its review of 
these information collections.
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above you may:
    [sbull] Access the Office of National Drug Control Policy Web site 
address at http://www.whitehousedrugpolicy.gov/prevent/survey; or
    [sbull] Call the Office of National Drug Control Policy, Office of 
Planning and Budget on (202) 395-6736.
    Interested persons are invited to send comments regarding the 
burden or any other aspect of these collections of information 
requirements. However, as noted above, comments on these information 
collection and/or recordkeeping requirements must be mailed and/or 
faxed to the designees referenced below, within 30 days from the date 
of publication:

Executive Office of the President, Office of National Drug Control 
Policy, Office of Planning and Budget, Attention: Terry S. Zobeck, 
Ph.D., Acting Deputy Associate Director for Planning and Budget, 
Washington, DC 20503, Fax Number: (202) 395-5571.
And, Office of Information and Regulatory Affairs, Office of Management 
and Budget, Washington, DC 20503, Fax Number: (202) 395-6974 or (202) 
395-5167, Attn: Allison Eydt, Desk Officer.

    Dated: June 16, 2003.
Terry S. Zobeck,
Acting Deputy Associate Director for Planning and Budget, Office of 
National Drug Control Policy. 1
[FR Doc. 03-15575 Filed 6-17-03; 1:06 pm]
BILLING CODE 3180-02-P